Answers are grounded in this paper and cite their sources.
Case report demonstrates significant improvement in lichen spinulosis with topical phosphodiesterase-4 inhibitor roflumilast over six months.
Lichen spinulosis is an uncommon, follicular keratotic disorder characterized by asymptomatic clusters of follicular papules with keratotic spines that primarily occurs in children, and rarely in adults. Various treatment options have been reported in the literature, although none are universally effective. Topical roflumilast (0.3%) is a recently approved phosphodiesterase-4 inhibitor first used in psoriasis which has shown reduction in hyperkeratosis in vitro. We report on an adult with symptomatic and recalcitrant lichen spinulosis who achieved significant improvement with the use of topical roflumilast over a 6-month period.
No takes yet. Share an insight, caveat, or question.
Karen Naert (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: